Activities of new antimicrobial agents (trovafloxacin, moxifloxacin, sanfetrinem, and quinupristin-dalfopristin) against Bacteroides fragilis group:: Comparison with the activities of 14 other agents

被引：25

作者：

Betriu, C ^{[1
]}

Gómez, M ^{[1
]}

Palau, ML ^{[1
]}

Sánchez, A ^{[1
]}

Picazo, JJ ^{[1
]}

机构：

[1] Hosp Clin San Carlos, Serv Microbiol Clin, Madrid 28040, Spain

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 1999年 / 43卷 / 09期

关键词：

D O I：

10.1128/AAC.43.9.2320

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

The antimicrobial activities of trovafloxacin, moxifloxacin, sanfetrinem, quinupristin-dalfopristin, and 14 other antimicrobial agents against 218 Bacteroides fragilis group strains were determined. A group of 10 imipenem-resistant strains were also tested. Imipenem, meropenem, and sanfetrinem had the lowest MICs of all of the beta-lactams. Quinupristin-dalfopristin inhibited all of the strains at 2 mu g/ml. Overall, the MICs of trovafloxacin and moxifloxacin for 90% of the strains tested were 1 and 2 mu g/ml, respectively.

引用

页码：2320 / 2322

页数：3

共 20 条

[1] A 5-YEAR MULTICENTER STUDY OF THE SUSCEPTIBILITY OF THE BACTEROIDES-FRAGILIS GROUP ISOLATES TO CEPHALOSPORINS, CEPHAMINS, PENICILLINS, CLINDAMYCIN, AND METRONIDAZOLE IN THE UNITED-STATES [J].

ALDRIDGE, KE ;

GELFAND, M ;

RELLER, LB ;

AYERS, LW ;

PIERSON, CL ;

SCHOENKNECHT, F ;

TILTON, RC ;

WILKINS, J ;

HENDERBERG, A ;

SCHIRO, DD ;

JOHNSON, M ;

JANNEY, A ;

SANDERS, CV .

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1994, 18 (04) :235-241

[2] Comparison of the in vitro activities of Bay 12-8039, a new quinolone, and other antimicrobials against clinically important anaerobes [J].

Aldridge, KE ;

Ashcraft, DS .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (03) :709-711

[3] SUSCEPTIBILITY OF 539 GRAM-POSITIVE AND GRAM-NEGATIVE ANAEROBES TO NEW AGENTS, INCLUDING RP59500, BIAPENEM, TROSPECTOMYCIN AND PIPERACILLIN TAZOBACTAM [J].

APPELBAUM, PC ;

SPANGLER, SK ;

JACOBS, MR .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1993, 32 (02) :223-231

[4] Interactions of B-Lactamases with sanfetrinem (GV 104326) compared to those with imipenem and with oral β-lactams [J].

Babini, GS ;

Yuan, MF ;

Livermore, DM .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (05) :1168-1175

[5] SUSCEPTIBILITY PATTERNS AND RESISTANCE TO IMIPENEM IN THE BACTEROIDES-FRAGILIS GROUP SPECIES IN JAPAN - A 4-YEAR STUDY [J].

BANDOH, K ;

UENO, K ;

WATANABE, K ;

KATO, N .

CLINICAL INFECTIOUS DISEASES, 1993, 16 :S382-S386

[6] RESISTANCE OF ANAEROBIC-BACTERIA TO ANTIMICROBIAL AGENTS IN SPAIN [J].

BAQUERO, F ;

REIG, M .

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1992, 11 (11) :1016-1020

[7] In-vitro susceptibilities of species of the Bacteroides fragilis group to newer β-lactam agents [J].

Betriu, C ;

Sánchez, A ;

Gómez, M ;

Palau, ML ;

Picazo, JJ .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 43 (01) :133-136

[8] CHANGES IN THE SUSCEPTIBILITY OF BACTEROIDES-FRAGILIS GROUP ORGANISMS TO VARIOUS ANTIMICROBIAL AGENTS 1979-1989 [J].

BETRIU, C ;

CABRONERO, C ;

GOMEZ, M ;

PICAZO, JJ .

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1992, 11 (04) :352-356

[9] In vitro and in vivo antibacterial activities of GV129606, a new broad-spectrum trinem [J].

DiModugno, E ;

Broggio, R ;

Erbetti, I ;

Lowther, J .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (12) :2742-2748

[10]

Dubreuil L, 1996, MED MALADIES INFECT, V26, P196

← 1 2 →